Advances in diagnostic technologies have highlighted the critical role of biosensors in modern healthcare, particularly following the COVID-19 pandemic, which underscored the importance of rapid, accurate, and accessible diagnostic tools. Early and reliable disease detection is fundamental to effective prevention, clinical decision-making, and patient management. In this context, nanotechnology offers transformative opportunities by enabling highly sensitive biomarker detection, continuous health monitoring, and high-resolution molecular diagnostics, thereby supporting the development of predictive, preventive, and personalized medicine.

​

Nanomaterials possess unique physicochemical properties that can be tailored to selectively recognize and transduce biological signals with exceptional sensitivity and specificity. By exploiting these properties, biosensors can achieve real-time detection of clinically relevant biomarkers at low concentrations, facilitating earlier diagnosis and improved disease monitoring.

 

Our Biosensors

At Nano4Med, we focus on developing next-generation electrochemical biosensors enhanced with functional nanomaterials, including:

• Carbon nanotubes

• Graphene

• Gold nanoparticles

• Other nanostructured materials

​​

By harnessing their electrocatalytic and surface-engineering capabilities, we aim to improve sensor sensitivity, selectivity, and analytical performance for in vitro detection of biomarkers associated with distinct disorders, including:

• Alzheimer's disease

• Parkinson's disease

• Stroke​

​

Through the integration of nanotechnology with biosensing platforms, our work contributes to the advancement of innovative diagnostic solutions for precision medicine.

​

​​